HCW Biologics Inc. Announces Its Lead Product Candidate Shown To Augment Anti-Tumor Activity And Reduce Side Effects Of Chemotherapy Regimens
HCW Biologics Inc. (the “Company”) (NASDAQ:HCWB), a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic,